已收盘 01-23 16:00:00 美东时间
0.000
0.00%
FDA以最快的步伐加速批准了美国医药巨头百时美施贵宝(BMY.US)旗下的重磅创新型细胞疗法Breyanzi (lisocabtagene maraleucel)治疗滤泡性淋巴瘤患者。
05-16 14:58
Bristol-Myers Squibb (NYSE:BMY) has returned the rights to a preclinical cancer drug candidate, an SOS1 inhibitor, back to Schrodinger (NASDAQ:SDGR). Schrodinger noted that it delivered a development ...
05-03 03:04
美國藥廠百時美施貴寶(BMY.US)公布首季業績。季度虧損119.11億美元,對上年度同期純利22.62億美元。每股季度虧損5.89美元。季度收入按年升4.7...
04-26 09:46
Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint not met, safety consistent. Also, positive Phase 3 results for Krazati (adagrasib) in KRASG12C-mutated NSCLC.
04-01 21:44
跨国药企财报基本披露完毕,新一年全球TOP10药企名单随之出炉。在疫情对业务的影响逐渐淡化后,各家药企也回归到正常发展节奏上,不过2023年的业务排名榜单还是有...
03-17 19:20
BOSTON, March 4, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat ...
03-04 20:30
①86岁的乔·刘易斯周三向纽约曼哈顿法庭承认证券欺诈等一系列罪名; ②虽然理论上他最高可被判处45年有期徒刑,但考虑到认罪协商和年龄因素,最终惩罚可能会非常有限。
01-25 01:25